aTYR PHARMA ATYR
NASDAQ ATYR
$0.38 +0.01 (+4.13%)
As of: Sep 21, 2026 · 10:48 AM EDT

aTYR PHARMA (ATYR) Operating Margin Growth (1y) (2020)

Analysis

aTYR PHARMA (ATYR) Operating Margin Growth (1y) (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 602.00
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn -16,814.00
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn -143.00
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 78.00
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn 7,666.00
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn 1,135.00
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 2,002.00
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn -2,881.00
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn -1.23 Mn
10 aTYR PHARMA 35.31 Mn -22.30 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 389,965.00
Sep 30, 2020 -141,196.00
Jun 30, 2020 265,821.00